Effect of Chronic Central Administration of Glucagon‐Like Peptide‐1 (7–36) Amide on Food Consumption and Body Weight in Normal and Obese Rats
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Glucagon‐like peptide (7–36) amide (GLP‐1) acutely inhibits food and water consumption in rats after intrace‐rebroventricular (icv) administration. To assess the potential for desensitization of these effects, we investigated the effects of chronic icv administration of GLP‐1 on food consumption and body weight in Sprague‐Dawley (SD) rats and Zucker (fa/fa) obese rats. In vitro functional densensitization of the GLP‐1 receptor was not observed after overnight exposure of Rin m5F insulinoma cells to GLP‐1 at concentrations up to 10 nM. Administration of GLP‐1 to SD rats (30 ug icv twice a day for 6 days) resulted in significant reductions in 24‐hour food consumption each day (25 ±1%). Continuous icv infusion of GLP‐1 for 7 and 14 days significantly inhibited cumulative food consumption and reduced body weight in SD rats. In the genetically obese Zucker rat, chronic dosing with GLP‐1 (30 ug icv) once a day for 6 days caused significant reductions in food consumption each day and a reduction in body weight. These results indicate that the GLP‐1 pathways in the central nervous system controlling food consumption do not desensitize after chronic exposure to GLP‐1 and suggest that agonists of the central GLP‐1 receptor may be effective agents for the treatment of obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Gutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868
Göke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474
Cited by
Enhancing Incretin Action for the Treatment of Type 2 Diabetes
Drucker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2929 · Cited by 579
Beta Glucan: Health Benefits in Obesity and Metabolic Syndrome
El Khoury, D., Cuda, C., Luhovyy, B. L., & Anderson, G. H. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/851362 · Cited by 538
Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.
Näslund, E., Barkeling, B., King, N., Gutniak, M., Blundell, J., Holst, J., Rössner, S., & Hellström, P. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800818 · Cited by 468
Graaf, C. D., Donnelly, D., Wootten, D., Lau, J., Sexton, P. M., Miller, L. J., Ahn, J.-M., Liao, J., Fletcher, M. M., Yang, D., et al. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011395 · Cited by 403
Hormonal regulation of food intake
Stanley, S., Wynne, K., McGowan, B., & Bloom, S. (2005) · Physiological Reviews · doi:10.1152/physrev.00015.2004 · Cited by 372
Metadata
- Authors
- Davis, H. R., Mullins, D. E., Pines, J. M., Hoos, L. M., France, C. F., Compton, D. S., Graziano, M. P., Sybertz, E. J., Strader, C. D., & Van Heek, M.
- Venue
- Obesity Research
- Publisher
- Wiley
- Published
- 1998-03
- Volume
- 6
- Issue
- 2
- Pages
- 147-156
- ISSN
- 1071-7323 (ISSN-L)
- 1550-8528
- OpenAlex
- W2088773875
- Cited by
- 55
- References
- 3
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Chronic Central Administration of Glucagon‐Like Peptide‐1 (7–36) Amide on Food Consumption and Body Weight in Normal and Obese Rats. https://app.cochat.ai/papers/10.1002/j.1550-8528.1998.tb00329.x
- The paper
- Davis, H. R., Mullins, D. E., Pines, J. M., Hoos, L. M., France, C. F., Compton, D. S., Graziano, M. P., Sybertz, E. J., Strader, C. D., & Van Heek, M. (1998). Effect of Chronic Central Administration of Glucagon‐Like Peptide‐1 (7–36) Amide on Food Consumption and Body Weight in Normal and Obese Rats. Obesity Research. https://doi.org/10.1002/j.1550-8528.1998.tb00329.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.